A detailed history of Resonant Capital Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 1,226 shares of VRTX stock, worth $552,889. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,226
Previous 1,081 13.41%
Holding current value
$552,889
Previous $506,000 12.65%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$460.0 - $505.78 $66,700 - $73,338
145 Added 13.41%
1,226 $570,000
Q2 2024

Aug 01, 2024

BUY
$392.81 - $485.53 $108,415 - $134,006
276 Added 34.29%
1,081 $506,000
Q1 2024

May 01, 2024

BUY
$407.69 - $446.08 $328,190 - $359,094
805 New
805 $336,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Resonant Capital Advisors, LLC Portfolio

Follow Resonant Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.